<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03297021</url>
  </required_header>
  <id_info>
    <org_study_id>GCO 17-1618</org_study_id>
    <nct_id>NCT03297021</nct_id>
  </id_info>
  <brief_title>Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting</brief_title>
  <official_title>Effects of Ondansetron Dose and Timing on Rates of Post-operative Nausea and Vomiting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to evaluate the effectiveness of three different regimens of prophylactic
      ondansetron on the incidence and severity of post-operative nausea and vomiting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be randomize to one of three arms: 4mg ondansetron pre-emergence, 8 mg
      ondansetron pre-emergence, or 4mg ondansetron pre-incision followed by 4mg ondansetron
      pre-emergence. Primary outcome will be incidence of PONV in the PACU prior to discharge.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 23, 2017</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>Random allocation by opaque envelope and random number generator. Investigator will draw up study medication and give to care-providers. Outcome assessor not present for drawing up of medications.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Post-operative nausea and vomiting</measure>
    <time_frame>average of 4 hours</time_frame>
    <description>Incidence of Post-operative nausea and vomiting prior to discharge from PACU</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Episodes of vomiting in the PACU</measure>
    <time_frame>average of 4 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of nausea or vomiting on post-operative day one</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of additional treatments needed to control nausea or vomiting in the PACU</measure>
    <time_frame>average of 4 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to discharge from PACU</measure>
    <time_frame>average of 4 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Post-operative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>Ondansetron 4mg Pre-emergence</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ondansetron 8mg Pre-emergence</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ondansetron Pre-Incision and Pre-emergence</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4mg Ondansetron Pre-Incision and 4mg Ondansetron Pre-emergence</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ondansetron 4 MG</intervention_name>
    <description>dose as per arm selection</description>
    <arm_group_label>Ondansetron 4mg Pre-emergence</arm_group_label>
    <arm_group_label>Ondansetron Pre-Incision and Pre-emergence</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ondansetron 8mg</intervention_name>
    <description>dose as per arm selection</description>
    <arm_group_label>Ondansetron 8mg Pre-emergence</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I, II, III presenting for ambulatory surgery to be performed under general
             anesthesia

        Exclusion Criteria:

          -  Patients with allergies or contraindications to study medications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Katz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel Katz, MD</last_name>
    <phone>212-241-7475</phone>
    <email>Daniel.katz@mountsinai.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2017</study_first_submitted>
  <study_first_submitted_qc>September 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2017</study_first_posted>
  <last_update_submitted>October 29, 2017</last_update_submitted>
  <last_update_submitted_qc>October 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Icahn School of Medicine at Mount Sinai</investigator_affiliation>
    <investigator_full_name>Daniel Katz</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>ambulatory surgery</keyword>
  <keyword>post-operative nausea and vomiting</keyword>
  <keyword>general anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ondansetron</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

